Search research articles
Contact Us
Filters
Showing results (501-510 of 512) with videos related to
Page
of 52
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
November 20, 2020
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 17, 2022
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery
David J Douin, Lianne Siegel, Greg Grandits, et al.
Med (New York, N.Y.)
|
August 13, 2022
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)
Eleftherios Mylonakis, Joseph Lutaakome, Mamta K Jain, et al.
Nature
|
October 19, 2001
Orbitally induced oscillations in the East Antarctic ice sheet at the Oligocene/Miocene boundary
T R Naish, K J Woolfe, P J Barrett, et al.
Scientific Reports
|
March 22, 2025
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)
Sofía Sábato, Susana Benet, Angela J Rogers, et al.
Annals of Internal Medicine
|
August 29, 2022
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
, Angela J Rogers, Deborah Wentworth, et al.
Journal of Medicinal Chemistry
|
February 2, 2023
Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists
James S Scott, Darren Stead, Bernard Barlaam, et al.
Journal of Medicinal Chemistry
|
September 10, 2020
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist
James S Scott, Thomas A Moss, Amber Balazs, et al.
The New England Journal of Medicine
|
December 28, 2020
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
, Jens D Lundgren, Birgit Grund, et al.
Annals of Internal Medicine
|
December 20, 2021
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial
, Jens D Lundgren, Birgit Grund, et al.
Page
of 52
Search research articles
Search
Showing results (501-510 of 512) with videos related to
Sort By:
Page
of 52
Medrxiv : the Preprint Server for Health Sciences
|
November 20, 2020
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 17, 2022
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery
David J Douin, Lianne Siegel, Greg Grandits, et al.
Med (New York, N.Y.)
|
August 13, 2022
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)
Eleftherios Mylonakis, Joseph Lutaakome, Mamta K Jain, et al.
Nature
|
October 19, 2001
Orbitally induced oscillations in the East Antarctic ice sheet at the Oligocene/Miocene boundary
T R Naish, K J Woolfe, P J Barrett, et al.
Scientific Reports
|
March 22, 2025
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)
Sofía Sábato, Susana Benet, Angela J Rogers, et al.
Annals of Internal Medicine
|
August 29, 2022
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
, Angela J Rogers, Deborah Wentworth, et al.
Journal of Medicinal Chemistry
|
February 2, 2023
Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists
James S Scott, Darren Stead, Bernard Barlaam, et al.
Journal of Medicinal Chemistry
|
September 10, 2020
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist
James S Scott, Thomas A Moss, Amber Balazs, et al.
The New England Journal of Medicine
|
December 28, 2020
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
, Jens D Lundgren, Birgit Grund, et al.
Annals of Internal Medicine
|
December 20, 2021
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial
, Jens D Lundgren, Birgit Grund, et al.
Page
of 52